HomeFile

File

View Category
Antithrombotic Anticoagulants

AHA 2019 | GALILEO-4D: Rivaroxaban in the Prevention of Post TAVR Valve Thickening and Thrombosis

This sub study of the GALILEO specifically looked at valve thickening and reduced leaflet motion after TAVR...
solaci -
Learn More
Chronic Ischemic cardiopathy

AHA 2019 | ISCHEMIA: The Invasive Approach (PCI or Surgery) Results Similar to Optimal Medical Treatment

After a several year follow up, the International Study of Comparative Health Effectiveness with Medical and Invasive...
solaci -
Learn More
Structural heart disease

Temporal Trends and Outcomes of TAVR in Bicuspids: Are We Any Better?

This large registry has shown bicuspid aortic stenosis (AS) patients have similar mortality with transcatheter aortic valve...
solaci -
Learn More
Acute coronary syndromes

Current Mechanical Complications of Infarction

Contemporary data of a recently published large registry show that mechanical complications after infarction are not frequent...
solaci -
Learn More
Structural heart disease

Europe Grants Approval to Balloon-Expandable Valve in Low-Risk Patients; Self-Expanding Valve Still Waiting for It

The balloon-expandable valve has been granted approval in Europe for treatment of the complete risk spectrum of...
solaci -
Learn More
Structural heart disease

Negative Impact of Pulmonary Hypertension in TAVR

Courtesy of Dr. Carlos Fava. The presence of pulmonary hypertension (PH) is frequent in severe aortic stenosis. This...
solaci -
Learn More
Chronic Ischemic cardiopathy

The Road Towards a “More Perfect” Angioplasty Is Already Being Traveled

The aim of revascularization, whether through angioplasty or surgery, is to restore adequate flow to the myocardium;...
solaci -
Learn More
Chronic Ischemic cardiopathy

Should Post-PCI Biomarkers Elevation Be of Concern?

Elevated markers after PCI in stable patients treated with the latest generation stents continues to happen. However,...
solaci -
Learn More